Table 4

Clinical events

Adverse events up to day 45±15Control (n=54)Hypothermia (n=47)Risk ratio (95% CI)P values
Death, n (%)2 (4)1 (2)0.57 (0.05 to 6.44)0.64
Ischaemia-driven target vessel revascularisation or ACBP, n (%)1 (2)0 (0)0.98 (0.95 to 1.02)0.35
VF/VT, n (%)7 (13)5 (11)0.80 (0.24 to 2.71)0.72
Stroke, n (%)1 (2)1 (2)1.15 (0.07 to 18.94)0.92
Heart failure, n (%)3 (6)3 (6)1.16 (0.22 to 6.04)0.90
Pneumonia/sepsis, n (%)2 (4)1 (2)0.57 (0.05 to 6.44)0.64
Any bleeding, n (%)5 (9)11 (23)2.99 (0.96 to 9.38)0.06
 Minimal bleeding, n (%)4 (7)6 (13)1.83 (0.48 to 6.92)0.51
 Minor bleeding, n (%)1 (2)4 (8)4.93 (0.53 to 45.76)0.18
 Major bleeding, n (%)0 (0)1 (2)1.02 (0.98 to 1.07)0.47
Any cause hospital admission, n (%)9 (17)4 (9)0.47 (0.13 to 1.62)0.22
  • ACBP, aortocoronary bypass; VF/VT, ventricular fibrillation/ventricular tachycardia.